Windlas Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech has submitted to BSE and NSE a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended June 30, 2025. MUFG confirmed that no dematerialization requests were received during the quarter. The RTA also noted that the company does not hold any physical shares, meaning all shares are already in demat form. The certificate was signed by Ananta Narayan Panda, Company Secretary, on July 9, 2025. This is a routine quarterly compliance filing under SEBI's Depositories Regulations.
No material impact on shareholders or stock price. This is a standard regulatory compliance disclosure with no business or financial information disclosed.